Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.
Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. Schlaak M, et al. Among authors: kurschat p. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008908. doi: 10.1002/14651858.CD008908.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2013 Aug 29;(8):CD008908. doi: 10.1002/14651858.CD008908.pub3. PMID: 22258991 Updated. Review.
Mast cells play a protumorigenic role in primary cutaneous lymphoma.
Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, Büttner R, Kurschat P, Mauch C, Roers A, Hartmann K. Rabenhorst A, et al. Among authors: kurschat p. Blood. 2012 Sep 6;120(10):2042-54. doi: 10.1182/blood-2012-03-415638. Epub 2012 Jul 26. Blood. 2012. PMID: 22837530 Free article.
Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.
Schlaak M, Kurschat P, Shimabukuro-Vornhagen A, Scheid C, Chemnitz J, Stadler R, von Bergwelt-Baildon M, Theurich S. Schlaak M, et al. Among authors: kurschat p. Transpl Immunol. 2011 Sep;25(2-3):163-6. doi: 10.1016/j.trim.2011.06.008. Epub 2011 Jul 2. Transpl Immunol. 2011. PMID: 21745569
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
Theurich S, Schlaak M, Steguweit H, Heukamp LC, Wennhold K, Kurschat P, Rabenhorst A, Hartmann K, Schlösser H, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Stadler R, von Bergwelt-Baildon M. Theurich S, et al. Among authors: kurschat p. J Clin Oncol. 2016 Apr 20;34(12):e110-6. doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27. J Clin Oncol. 2016. PMID: 25348001 No abstract available.
[Personalized therapy concepts for malignant melanoma].
Schlaak M, Kreuzberg N, Mauch C, Kurschat P. Schlaak M, et al. Among authors: kurschat p. Internist (Berl). 2013 Feb;54(2):188-93. doi: 10.1007/s00108-012-3155-x. Internist (Berl). 2013. PMID: 23371260 German.
47 results